Overview

Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is a randomised study to be conducted in patients with severe to very severe Chronic Obstructive Pulmonary Disease (COPD) to establish whether there is a need for these patients to be continuously treated with an inhaled corticosteroid on top of two potent long-acting bronchodilators. The study also aims to identify the type of patients who are likely to benefit from inhaled corticosteroid maintenance therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Fluticasone
Salmeterol Xinafoate
Tiotropium Bromide
Xhance